Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative-Reference-Cited by-同舟云学术

Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer’s Disease Neuroimaging Initiative

Published:2020-10-26 Issue:2 Volume:26 Page:429-442
ISSN:1359-4184
Container-title:Molecular Psychiatry
language:en
Short-container-title:Mol Psychiatry

Author:

Karikari Thomas K.,Benedet Andréa L.,Ashton Nicholas J.,Lantero Rodriguez Juan,Snellman Anniina^ORCID,Suárez-Calvet Marc^ORCID,Saha-Chaudhuri Paramita^ORCID,Lussier Firoza,Kvartsberg Hlin,Rial Alexis Moscoso^ORCID,Pascoal Tharick A.,Andreasson Ulf,Schöll Michael^ORCID,Weiner Michael W.,Rosa-Neto Pedro,Trojanowski John Q.,Shaw Leslie M.,Blennow Kaj^ORCID,Zetterberg Henrik^ORCID,

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Psychiatry and Mental health,Molecular Biology

Link

https://www.nature.com/articles/s41380-020-00923-z.pdf

Reference44 articles.

1. Blennow K, Leon MJ, de, Zetterberg H. Alzheimer’s disease. Lancet. 2006;368:387–403.

2. Jack CR, Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, et al. Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12:207–16.

3. Ashton NJ, Schöll M, Heurling K, Gkanatsiou E, Portelius E, Höglund K, et al. Update on biomarkers for amyloid pathology in Alzheimer’s disease. Biomark Med. 2018;12:799–812.

4. Schöll M, Maass A, Mattsson N, Ashton NJ, Blennow K, Zetterberg H, et al. Biomarkers for tau pathology. Mol Cell Neurosci. 2019;97:18–33.

5. Skillbäck T, Farahmand BY, Rosén C, Mattsson N, Nägga K, Kilander L, et al. Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia. Brain 2015;138:2716–31.

Cited by 226 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma p-tau181 and amyloid markers in Alzheimer’s disease: A comparison between Lumipulse and SIMOA;Neurobiology of Aging;2024-11

2. Association between blood-based protein biomarkers and brain MRI in the Alzheimer’s disease continuum: a systematic review;Journal of Neurology;2024-09-12

3. Alzheimer’s disease biomarkers and their current use in clinical research and practice;Molecular Psychiatry;2024-09-04

4. Elucidating the Functional Roles of Long Non-Coding RNAs in Alzheimer’s Disease;International Journal of Molecular Sciences;2024-08-25

5. The diagnostic value of plasma phosphorylated tau 181 in Alzheimer’s disease within the Chinese population: A systematic review and meta-analysis;2024-08-16